Association of Bacillus Calmette–Guerin shortages with bladder cancer recurrence: A single-center retrospective study

Single Center ◽

Faculty Opinions recommendation of Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3246962.2931060 ◽

2010 ◽

Author(s):

Juan Palou Redorta ◽

Guillermo Urdaneta

Keyword(s):

Bladder Cancer ◽

Cancer Recurrence ◽

Invasive Bladder Cancer ◽

Scoring Model ◽

Nonmuscle Invasive Bladder Cancer

Sufficient prophylactic efficacy with minor adverse effects by intravesical instillation of low-dose bacillus Calmette-Guerin for superficial bladder cancer recurrence

International Journal of Urology ◽

10.1046/j.0919-8172.2003.00607.x ◽

2003 ◽

Vol 10 (4) ◽

pp. 183-189 ◽

Cited By ~ 24

Author(s):

AKIRA IRIE ◽

TOYOAKI UCHIDA ◽

HIDEYUKI YAMASHITA ◽

KAZUMASA MATSUMOTO ◽

TAKEFUMI SATOH ◽

...

Keyword(s):

Bladder Cancer ◽

Adverse Effects ◽

Low Dose ◽

Superficial Bladder Cancer ◽

Cancer Recurrence ◽

Intravesical Instillation ◽

Prophylactic Efficacy ◽

Polymorphism in autophagy gene ATG2B is not associated with bladder cancer recurrence after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy in Asian patients.

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2020.11.015 ◽

2020 ◽

Author(s):

Zhijiang Zang ◽

Yew Koon Lim ◽

Yiong Huak Chan ◽

Lata Raman ◽

Kesavan Esuvaranathan ◽

...

Keyword(s):

Bladder Cancer ◽

Cancer Recurrence ◽

Bcg Immunotherapy ◽

Asian Patients ◽

Autophagy Gene ◽

Usefulness of the Spanish Urological Club for Oncological Treatment Scoring Model to Predict Nonmuscle Invasive Bladder Cancer Recurrence in Patients Treated With Intravesical Bacillus Calmette-Guérin Plus Interferon-α

10.1016/j.juro.2010.08.083 ◽

2011 ◽

Vol 185 (1) ◽

pp. 67-71 ◽

Cited By ~ 17

Author(s):

Henry M. Rosevear ◽

Andrew J. Lightfoot ◽

Kenneth G. Nepple ◽

Michael A. O'Donnell

Keyword(s):

Bladder Cancer ◽

Cancer Recurrence ◽

Invasive Bladder Cancer ◽

Interferon Α ◽

Scoring Model ◽

Oncological Treatment ◽

Nonmuscle Invasive Bladder Cancer

Results of a phase I/II single arm clinical trial assessing efficacy, safety and tolerability of the recombinant Bacillus Calmette Guérin VPM1002BC in patients with non-muscle invasive bladder cancer recurrence after BCG induction with or without BCG maintenance therapy – SAKK 06/14

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2020.10.027 ◽

2020 ◽

Vol 38 (12) ◽

pp. 898

Author(s):

Cyrill A Rentsch ◽

George N Thalmann ◽

Ilaria Lucca ◽

Maciej Kwiatkowski ◽

Grégory J Wirth ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Maintenance Therapy ◽

Phase I ◽

Cancer Recurrence ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

10.1016/j.juro.2009.07.016 ◽

2009 ◽

Vol 182 (5) ◽

pp. 2195-2203 ◽

Cited By ~ 253

Author(s):

Jesus Fernandez-Gomez ◽

Rosario Madero ◽

Eduardo Solsona ◽

Miguel Unda ◽

Luis Martinez-Piñeiro ◽

...

Keyword(s):

Bladder Cancer ◽

Cancer Recurrence ◽

Invasive Bladder Cancer ◽

Scoring Model ◽

Nonmuscle Invasive Bladder Cancer

A Retrospective Analysis of 153 Patients Treated With or Without Intravesical Bacillus Calmette-Guerin for Primary Stage T1 Grade 3 Bladder Cancer: Recurrence, Progression and Survival

10.1097/00005392-200301000-00024 ◽

2003 ◽

pp. 96-100 ◽

Cited By ~ 5

Author(s):

OSAMA SHAHIN ◽

GEORGE N. THALMANN ◽

CYRILL RENTSCH ◽

L. MAZZUCCHELLI ◽

U. E. STUDER

Keyword(s):

Bladder Cancer ◽

Retrospective Analysis ◽

Cancer Recurrence ◽

Primary Stage ◽

Grade 3 ◽

Stage T1

A Retrospective Analysis of 153 Patients Treated With or Without Intravesical Bacillus Calmette-Guerin for Primary Stage T1 Grade 3 Bladder Cancer: Recurrence, Progression and Survival

10.1016/s0022-5347(05)64044-x ◽

2003 ◽

Vol 169 (1) ◽

pp. 96-100 ◽

Cited By ~ 155

Author(s):

OSAMA SHAHIN ◽

GEORGE N. THALMANN ◽

CYRILL RENTSCH ◽

L. MAZZUCCHELLI ◽

U.E. STUDER

Keyword(s):

Bladder Cancer ◽

Retrospective Analysis ◽

Cancer Recurrence ◽

Primary Stage ◽

Grade 3 ◽

Stage T1

A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non–muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

European Urology Oncology ◽

10.1016/j.euo.2021.12.006 ◽

2022 ◽

Author(s):

Cyrill A. Rentsch ◽

George N. Thalmann ◽

Ilaria Lucca ◽

Maciej Kwiatkowski ◽

Grégory J. Wirth ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Phase 1 ◽

Cancer Recurrence ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Bcg Therapy ◽

Muscle Invasive ◽

238: Combined Effect of Apoptotic Biomarkers on Bladder Cancer Recurrence and Mortality after Radical Cystectomy

10.1016/s0022-5347(18)30503-2 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 79-80

Author(s):

Jose A. Karam ◽

Yair Lotan ◽

Raheela Ashfaq ◽

Claus G. Roehrborn ◽

Arthur I. Sagalowsky ◽

...

Keyword(s):

Bladder Cancer ◽

Radical Cystectomy ◽

Cancer Recurrence ◽

Combined Effect ◽